Zeolite-fibrin clot composite as a haemostatic agent for haemophilia A

Abstract

Zeolite is a multifunctional material, which recently exhibited promising prospects in emerging biological and medical applications. This study reported a new bio-inorganic hybrid of zeolite-fibrin clot composite serving as haemostatic agent in haemophilia A. The zeolite-fibrin clot composite promoted haemocompatibility and helped to achieve short clotting time both in vitro (22 ± 3 s vs. >600 s) and in vivo (4.5 min vs. >60 min) compared to control in coagulation factor VIII deficiency bleeding model. Therefore, in situations of surgical operation or accidental injury, this effective and ready-to-use haemostatic agent may provide rapid haemostasis for haemophilia A patients.

Keywords

Zeolite-fibrin clot composite haemostatic agent haemophilia A

Get full access to this article

View all access options for this article.

References

Johansson

Stensballe

Oliveri

et al . How I treat patients with massive hemorrhage. Blood 2014; 124: 3051–3058.

Rossaint

Bouillon

Cerny

et al . The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016; 20: 100–100.

Rodeghiero

Castaman

Tosetto

How I treat von Willebrand disease. Blood 2009; 114: 1158–1165.

Mannucci

PM.

Back to the future: a recent history of haemophilia treatment. Haemophilia 2008; 14: 10–18.

Motto

Paola

JD.

Diagnostic approach to von Willebrand disease. Blood 2015; 125: 2029–2037.

Graw

Brackmann

Oldenburg

et al . Haemophilia A: from mutation analysis to new therapies. Nat Rev Genet 2005; 6: 488–501.

Schramm

The history of haemophilia – a short review. Thromb Res 2014; 134: S4–S9.

Peyvandi

Garagiola

Young

The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet 2016; 388: 187–197.

Franchini

Mannucci

PM.

Hemophilia A in the third millennium. Blood Rev 2013; 27: 179–184.

10.

Srivastava

Brewer

Mauserbunschoten

et al . Guidelines for the management of hemophilia. Haemophilia 2013; 19: e1–e47.

11.

Wight

Paisley

et al . Control of bleeding in patients with haemophilia A with inhibitors: a systematic review. Haemophilia 2003; 9: 464–520.

12.

Von Depka

Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety. Haemophilia 2005; 11: 18–23.

13.

Stephensen

Tait

Brodie

et al . Changing patterns of bleeding in patients with severe haemophilia A. Haemophilia 2009; 15: 1210–1214.

14.

Quintana-Molina

Martinez-Bahamonde

Gonzalez-Garcia

et al . Surgery in haemophilic patients with inhibitor: 20 years of experience. Haemophilia 2004; 10: 30–40.

15.

Granville-Chapman

Jacobs

Midwinter

MJ.

Pre-hospital haemostatic dressings: a systematic review. Injury 2011; 42: 447–459.

16.

Bennett

Littlejohn

Review of new topical hemostatic dressings for combat casualty care. Mil Med 2014; 179: 497–514.

17.

Voelker

From soldiers to civilians. JAMA 2016; 315: 456–2

18.

Pourshahrestani

Zeimaran

Djordjevic

et al . Inorganic hemostats: the state-of-the-art and recent advances. Mater Sci Eng C Mater Biol Appl 2016; 58: 1255–1268.

19.

Liao

Zhang

et al . In situ generated thrombin in the protein corona of zeolites: relevance of the functional proteins to its biological impact. Nano Res 2014; 7: 1457–1465.

20.

Lane

Philippou

Huntington

JA.

Directing thrombin. Blood 2005; 106: 2605–2612.

21.

Huey

Basadonna

Methods of providing hemostasis in anti-coagulant blood. US20080254146A1, USA, 2008.

22.

Long

Zhang

Huang

et al . Emerging nanoclay composite for effective hemostasis. Adv Funct Mater 2018; 28: 1704452.

23.

Baker

Sawvel

Zheng

et al . Controlling bioprocesses with inorganic surfaces: layered clay hemostatic agents. Chem Mater 2007; 19: 4390–4392.

24.

Monopoli

Walczyk

Campbell

et al . Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011; 133: 2525–2534.

25.

Rahimi

Bakhtiari

et al . Zeolite nanoparticles for selective sorption of plasma proteins. Sci Rep 2015; 5: 17259–2.

26.

Yildirim

Ozgur

Bayindir

Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption. J Mater Chem B 2013; 1: 1909–1920.

27.

Kavakli

Fibrin glue and clinical impact on haemophilia care. Haemophilia 1999; 5: 392–396.

28.

Bayır

Eryılmaz

Demirbilek

et al . Comparison of the topical haemostatic efficacy of nano-micro particles of clinoptilolite and kaolin in a rat model of haemorrhagic injury. Eur J Trauma Emerg Surg 2016; 42: 77–86.

29.

Arnaud

Tomori

Carr

et al . Exothermic reaction in zeolite hemostatic dressings: QuikClot ACS and ACS+®. Ann Biomed Eng 2008; 36: 1708–1713.

30.

Fathi

Sikorski

Christodoulides

et al . Zeolite-loaded alginate-chitosan hydrogel beads as a topical hemostat. J Biomed Mater Res B Appl Biomater 2018; 106: 1662–1671.

31.

Xiang

et al . Fabrication of a photo-crosslinked gelatin hydrogel for preventing abdominal adhesion. RSC Adv 2016; 6: 92449–92453.

32.

Chen

Guo

Wicks

et al . Quickly promoting angiogenesis by using a DFO-loaded photo-crosslinked gelatin hydrogel for diabetic skin regeneration. J Mater Chem B 2016; 4: 3770–3781.

33.

Sun

Zheng

Cheng

et al . Two-dimensional electrospun nanofibrous membranes for promoting random skin flap survival. RSC Adv 2016; 6: 9360–9369.

34.

McManus

Hurtado

Pusateri

et al . A case series describing thermal injury resulting from zeolite use for hemorrhage control in combat operations. Prehospital Emerg Care 2007; 11: 67–71.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB